Dorothee Vandevenne SRL
Dorothee Vandevenne reported total assets of 64,554 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Apr 2026).
The score of Dorothee Vandevenne shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -26 % Total assets +3 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dorothee Vandevenne's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Apr 2026
- Year ended 31 Dec 2024filed on 02 Apr 2025
- Year ended 31 Dec 2023filed on 17 Apr 2024
- Year ended 31 Dec 2022filed on 20 Mar 2023
- Year ended 31 Dec 2021filed on 22 Apr 2022
Dorothee Vandevenne's financial analysis
- Solvency56.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dorothee Vandevenne
Dorothee Vandevenne's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0702.942.568
- VAT number
- BE0702942568
- Peppol
- Registered · 0208:0702942568 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Sep 2018
- Registered office
- 3550 Heusden-Zolder
- Latest accounts
- 2025 · filed on 22 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Dorothee Vandevenne (SRL) has been based in Heusden-Zolder since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 16,761 € and equity of 36,711 €; its revenue is not published. Its solvency stands at 56.9%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dorothee Vandevenne
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- Pharma Laenen Retail sale of pharmaceutical products Geel · balance sheet 64,760 €
- Paula Cosmina Retail sale of pharmaceutical products Ganshoren · balance sheet 64,266 €
- Liscicom Retail sale of pharmaceutical products Bruges · balance sheet 63,926 €
- TV Retail sale of pharmaceutical products Haacht · balance sheet 65,446 €
- Beukeleirs Holding Retail sale of pharmaceutical products Vielsalm · balance sheet 66,647 €
- Niemegeers Karolien Retail sale of pharmaceutical products Bonheiden · balance sheet 61,719 €
- Pharmacien Independant Pierre Burniaux Retail sale of pharmaceutical products Philippeville · balance sheet 61,668 €
Frequently asked questions about Dorothee Vandevenne
What is the revenue of Dorothee Vandevenne?
Dorothee Vandevenne files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dorothee Vandevenne?
In Belgium, the VAT number is the company number prefixed with BE: BE0702942568 for Dorothee Vandevenne, if the company is VAT-registered. Its company number (CBE) is 0702.942.568.
Where is the registered office of Dorothee Vandevenne?
According to the CBE register, the registered office of Dorothee Vandevenne is in 3550 Heusden-Zolder.
What is the equity of Dorothee Vandevenne?
At the close of the 2025 financial year, the equity of Dorothee Vandevenne amounts to 36,711 €, a solvency of 56.9% of total assets.
Who manages Dorothee Vandevenne?
The register lists 1 active mandates at Dorothee Vandevenne. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dorothee Vandevenne
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →